In the final episode, Overcoming Barriers and Future Integration of Subcutaneous Therapies in Lung Cancer, the panelists ...
This episode, titled Optimizing Subcutaneous Therapies in NSCLC: Practical Integration, Patient Selection, and Workflow ...
Is it possible to train the body to resist seasonal allergies? That’s the hope promised by a new line of immunotherapy ...
As NAD+ injections and IV drips trend from TikTok to the Kardashians, the science of longevity remains a work in progress.
Danielle Griffiths and colleagues argue that the rise in invasive cosmetic procedures demands tighter regulation, better ...
Glenis Scadding still remembers one of her first patients for sublingual immunotherapy, forty years later. His hay fever was ...
Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes: Our Bureau, Mumbai Saturday, March 21, 2026, 13:30 Hrs [IST] Dr Red ...
Dr. Reddy’s Laboratories has launched ‘Obeda’, an injectable semaglutide therapy for diabetes and weight management in India.
HIV is preventable, yet new diagnoses continue in AZ at higher-than-average rates. Could a new, twice-yearly shot called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results